Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005470405
Thu, 03.10.2024
LANXESS Aktiengesellschaft
Ad hoc according to Art. 17 paragraph 1 MAR
LANXESS signs contract to sell Urethane Systems business for an enterprise value of €460 m to UBE Corporation - proceeds will be used to reduce net financial debt
Specialty chemicals company LANXESS signed a contract to sell its Urethane Systems business to UBE Corporation on 3rd October, [ … ]
Wed, 17.07.2024
LANXESS Aktiengesellschaft
Ad hoc according to Art. 17 paragraph 1 MAR
LANXESS: EBITDA pre exceptionals for second quarter 2024 significantly above market expectation
Specialty chemicals company LANXESS expects to achieve a second quarter 2024 EBITDA pre exceptionals that considerably exceeds average market expectation and previous year's level.
The preliminary [ … ]
Tue, 27.02.2024
LANXESS Aktiengesellschaft
Ad hoc according to Art. 17 paragraph 1 MAR
Impairment of goodwill and adjustment of at-equity book value of minority interest in Envalior
During the preparation of annual financial statements for the year 2023, LANXESS identified an impairment requirement on goodwill amounting to EUR 413 million. The impairment incurred in the Busine [ … ]
Mon, 06.11.2023
LANXESS Aktiengesellschaft
Ad hoc according to Art. 17 paragraph 1 MMVOLANXESS adjusts expectations for FY 2023;
Board of Management proposes dividend reduction
Demand in the fourth quarter for specialty chemical products of LANXESS is expected to be lower than estimated. Initiated destocking of customers in the agroindustry and a supplier-related production limitation for [ … ]
Mon, 19.06.2023
LANXESS Aktiengesellschaft
Ad hoc according to Art. 17 paragraph 1 MMVO
LANXESS: Results for Q2 and FY 2023 estimated below market expectations
Specialty chemicals company LANXESS expects second quarter 2023 EBITDA pre exceptionals to remain below average market expectations. Therefore, the company adjusts the outlook for FY 2023 downward as well.
EBITDA pre [ … ]
Mon, 19.06.2023
LANXESS Aktiengesellschaft
Ad hoc according to Art. 17 paragraph 1 MMVO
LANXESS: Results for Q2 and FY 2023 estimated below market expectations
Specialty chemicals company LANXESS expects second quarter 2023 EBITDA pre exceptionals to remain below average market expectations. Therefore, the company adjusts the outlook for FY 2023 downward as well.
EBITDA pre [ … ]
Tue, 31.05.2022
LANXESS Aktiengesellschaft
Ad hoc according to Art. 17 paragraph 1 MMVOLANXESS and Advent International establish a leading global joint venture for high-performance engineering polymers
LANXESS transfers High-Performance Materials business into joint venture
LANXESS High Performance Materials business valued at EUR 2.5 billion.
LANXESS receives a payment of at least EUR [ … ]
Tue, 19.04.2022
LANXESS Aktiengesellschaft
Ad hoc according to Art. 17 paragraph 1 MMVO
LANXESS Aktiengesellschaft: Strong start into the year - first quarter 2022 expected to exceed market expectations
- Growth of EBITDA pre exceptionals of 32 percent expected compared to prior-year quarter
- Expected EBITDA pre exceptionals of EUR 320 million around 7 percent above average market exp [ … ]
Tue, 24.08.2021
LANXESS Aktiengesellschaft
Ad hoc according to Art. 17 paragraph 1 MMVO
LANXESS signs contract to acquire Microbial Control business of IFF
Cologne, August 23, 2021 - Specialty chemicals company LANXESS has signed an agreement to acquire the microbial control business from the US-based company International Flavors & Fragrances Inc. (IFF). The acquisition will create o [ … ]
Tue, 26.01.2021
LANXESS Aktiengesellschaft
Ad hoc according to Art. 17 paragraph 1 MMVO
LANXESS Aktiengesellschaft: EBITDA pre exceptionals for fourth quarter 2020 estimated above market expectations
Specialty chemicals company LANXESS expects to achieve fourth quarter 2020 EBITDA pre exceptionals that considerably exceeds average market expectations and previous year's level.
EBITDA pre ex [ … ]